Investing.comCodex · 实盘不做把握 7/10
北京时间·🕒 发布 08-03 20:16:31时区推断·⟳ 抓取 08-03 20:17:08·⚡ 决策 08-04 10:03:33 +13h46m·84.5 天前
Modular Medical计划10月在五个美国市场推出Pivot贴片泵
五个市场覆盖14%的高量胰岛素泵处方医生、15%的新增泵启动和21%的高新品牌采纳医生，但只是商业化选区计划。
📄 原文Investing.com↗ 原文
Modular Medical to launch insulin pump in five U.S. markets
Oil falls over 4% as Trump calls off Iran strike, announces fresh talks SAN DIEGO - Modular Medical, Inc. (NASDAQ:MODD)…
不做 Modular Medical（MODD.US）
五市场商业化计划方向正面但非首次解锁，未披露订单或收入目标，且股价未确认，当前不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- 公司此前披露Pivot获得FDA 510(k) clearance，并称面向约30亿美元'almost-pumper'市场。
- 公司已宣布Pivot在美国商业可用，商业扩张活动预计2026年四季度开始。
- 本次披露五个首批市场及14%/15%/21%的处方相关覆盖数据。市场反应:MODD.US 2026-08-03收跌7.11%。
关键理由
- 五个市场覆盖14%的高量胰岛素泵处方医生、15%的新增泵启动和21%的高新品牌采纳医生，但只是商业化选区计划。
- Pivot已在6月宣布美国商业可用并开始发货，本次不是FDA clearance或首次商业化解锁。
- MODD.US在8月3日反而收跌7.11%，市场没有把本次选区计划视为强催化。
主要风险
- 未披露销售目标、ASP、报销覆盖或初期订单量，无法估算2026年收入增量。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-06-24 · 影响 weakens
关键商业化里程碑已于6月披露，削弱8月五市场计划的新鲜度。
检索:Modular Medical Pivot commercially available June 2026 commercial expansion Q4 2026 原文 ↗
工具调用 · 历史记录,结果未知(1 种)
- stock_quote · 结果未知
原文全文
展开原文 · 1,691 字
Oil falls over 4% as Trump calls off Iran strike, announces fresh talks
SAN DIEGO - Modular Medical, Inc. (NASDAQ:MODD) announced plans to begin commercialization of its Pivot tubeless patch pump in five U.S. markets starting in October 2026, according to a press release statement.
The initial rollout will include Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia. The company selected these markets based on analysis of insurance claim, prescription, and market adoption data spanning more than 100 U.S. markets.
The five markets collectively account for 14% of the nation’s highest volume insulin pump prescribers, 15% of all new insulin pump starts, and 21% of prescribers with high affinity for new brand adoption for patients using multiple daily injections, according to PurpleLab medical and pharmacy claims data for the 24 months ended June 2025.
"Launching Pivot in these five markets represents a critical first step in our commercialization strategy," said Jeb Besser, CEO of Modular Medical. "Pivot was developed to address these barriers by delivering a simpler insulin delivery experience designed around the needs of both the patients and providers."
The company has partnered with Inizio, a commercialization partner, to support the launch. Inizio will provide commercial execution, provider engagement, and launch support resources for the rollout.
Modular Medical is a commercial-stage medical device company focused on insulin delivery technologies. The Pivot tubeless patch pump is designed for individuals requiring intensive insulin therapy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
SAN DIEGO - Modular Medical, Inc. (NASDAQ:MODD) announced plans to begin commercialization of its Pivot tubeless patch pump in five U.S. markets starting in October 2026, according to a press release statement.
The initial rollout will include Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia. The company selected these markets based on analysis of insurance claim, prescription, and market adoption data spanning more than 100 U.S. markets.
The five markets collectively account for 14% of the nation’s highest volume insulin pump prescribers, 15% of all new insulin pump starts, and 21% of prescribers with high affinity for new brand adoption for patients using multiple daily injections, according to PurpleLab medical and pharmacy claims data for the 24 months ended June 2025.
"Launching Pivot in these five markets represents a critical first step in our commercialization strategy," said Jeb Besser, CEO of Modular Medical. "Pivot was developed to address these barriers by delivering a simpler insulin delivery experience designed around the needs of both the patients and providers."
The company has partnered with Inizio, a commercialization partner, to support the launch. Inizio will provide commercial execution, provider engagement, and launch support resources for the rollout.
Modular Medical is a commercial-stage medical device company focused on insulin delivery technologies. The Pivot tubeless patch pump is designed for individuals requiring intensive insulin therapy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。